Literature DB >> 15158638

When are observational studies as credible as randomised trials?

Jan P Vandenbroucke1.   

Abstract

Mesh：

Year:  2004        PMID： 15158638     DOI： 10.1016/S0140-6736(04)16261-2

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  127 in total

1.  Benefits and harms of drug treatments.

Authors:  Jan P Vandenbroucke
Journal:  BMJ       Date:  2004-07-03

2.  Statins and sepsis - scientifically interesting but clinically inconsequential.

Authors:  Dean T Eurich; Sumit R Majumdar
Journal:  J Gen Intern Med       Date:  2012-03       Impact factor: 5.128

Review 3.  Outcome of acute kidney injury in severe burns: a systematic review and meta-analysis.

Authors:  Nele Brusselaers; Stan Monstrey; Kirsten Colpaert; Johan Decruyenaere; Stijn I Blot; Eric A J Hoste
Journal:  Intensive Care Med       Date:  2010-03-24       Impact factor: 17.440

Review 4.  The epidemiological concept of residual risk.

Authors:  Diego Vanuzzo
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 5.  Some challenges for medical statistics.

Authors:  David R Cox
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

6.  Clinical trials report. Good news and bad news: now the bad news.

Authors:  Norman M Kaplan
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

Review 7.  Guidelines for the management of osteoporosis: the present and the future.

Authors:  Juliet Compston
Journal:  Osteoporos Int       Date:  2005-06-28       Impact factor: 4.507

Review 8.  How to optimize the evaluation and use of antibiotics in neonates.

Authors:  Evelyne Jacqz-Aigrain; Florentia Kaguelidou; John N van den Anker
Journal:  Pediatr Clin North Am       Date:  2012-09-01       Impact factor: 3.278

9.  Health outcome priorities among competing cardiovascular, fall injury, and medication-related symptom outcomes.

Authors:  Mary E Tinetti; Gail J McAvay; Terri R Fried; Heather G Allore; Joanna C Salmon; Joanne M Foody; Luann Bianco; Sandra Ginter; Liana Fraenkel
Journal:  J Am Geriatr Soc       Date:  2008-07-24       Impact factor: 5.562

Review 10.  Pharmacoeconomic evaluations of pharmacogenetic and genomic screening programmes: a systematic review on content and adherence to guidelines.

Authors:  Stefan Vegter; Cornelis Boersma; Mark Rozenbaum; Bob Wilffert; Gerjan Navis; Maarten J Postma
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.